A. Balsari

M. Rusnati, A. Balsari, F. Gargiulo, 1995, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

Reprogramming the lung microenvironment by inhaled immunotherapy fosters immune destruction of tumor

M. Campiglio, N. Zaffaroni, E. Tagliabue, 2016, Oncoimmunology.

The HER2 World: Better Treatment Selection for Better Outcome.

M. Campiglio, S. Ménard, E. Tagliabue, 2011, Journal of the National Cancer Institute. Monographs.

Natural antibodies to IL-2

A. Balsari, A. Caruso, 1997 .

Antibody Response after Vaccination with Antigen-Pulsed Dendritic Cells

S. Ménard, D. Morelli, E. Tagliabue, 2004, The International journal of biological markers.

Antibody response after vaccination with antigen-pulsed dendritic cells.

D. Morelli, E. Tagliabue, A. Balsari, 2004, The International journal of biological markers.

EGFR through STAT3 modulates ΔN63α expression to sustain tumor‐initiating cell proliferation in squamous cell carcinomas

R. Mantovani, A. Neri, S. Borrelli, 2013, Journal of cellular physiology.

Crossover electrophoresis with indirect immunofluorescence in the detection of soy protein in heated meat products

C. Cantoni, A. Balsari, G. Poli, 2007 .

Modulation of drug-induced cytotoxicity by a bispecific monoclonal antibody that recognizes the epidermal growth factor receptor and doxorubicin

S. Ménard, A. Sardini, D. Morelli, 1994, Cancer Immunology and Immunotherapy.

Oral administration of anti-doxorubicin monoclonal antibody prevents chemotherapy-induced gastrointestinal toxicity in mice.

S. Ménard, D. Morelli, A. Balsari, 1996, Cancer research.

Generation of CD28− cells from long‐term‐stimulated CD8+CD28+ T cells: a possible mechanism accounting for the increased number of CD8+CD28− T cells in HIV‐1‐infected patients

E. Garrafa, A. Balsari, L. Imberti, 1999, Journal of leukocyte biology.

Poly(I:C) and CpG-ODN combined aerosolization to treat lung metastases and counter the immunosuppressive microenvironment

C. Tripodo, N. Zaffaroni, E. Tagliabue, 2015, Oncoimmunology.

Apoptosis induction by trastuzumab: possible role of the core biopsy intervention.

M. Campiglio, S. Ménard, Alberto Costa, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Topical administration of a doxorubicin-specific monoclonal antibody prevents drug-induced mouth apoptosis in mice

S. Ménard, I. Barajon, C. Rumio, 2001, British Journal of Cancer.

Oligodeoxynucleotides in Mice Antitumor Activity Induced by CpG Absence of the CD1 Molecule Up-Regulates

S. Ménard, M. Colombo, M. Taniguchi, 2002 .

Effect of a bifunctional monoclonal antibody directed against a tumor marker and doxorubicin on the growth of epidermoid vulvar carcinoma grafted in athymic mice

S. Ménard, D. Morelli, A. Balsari, 2007, Cell Biophysics.

Degranulation of paneth cells via toll-like receptor 9.

S. Ménard, C. Rumio, A. Balsari, 2004, The American journal of pathology.

Modulation of peripheral blood immune cells by early use of steroids and its association with clinical outcomes in patients with metastatic non-small cell lung cancer treated with immune checkpoint inhibitors

V. Torri, A. Sica, F. D. De Braud, 2019, ESMO Open.

Dermatophytes in clinically healthy laboratory animals

A. Cocilovo, A. Balsari, I. Dragoni, 1981, Laboratory animals.

Innate immunity in breast carcinoma.

S. Ménard, A. Balsari, L. Sfondrini, 2003, Endocrine-related cancer.

Aspergillus fumigatus and specific precipitins in dogs with turbinate changes

A. Balsari, C. Mortellaro, G. Poli, 1981, Veterinary Record.

Low Molecular Weight Hyaluronic Acid Increases the Self-Defense of Skin Epithelium by Induction of β-Defensin 2 via TLR2 and TLR4

Marco Palazzo, C. Rumio, A. Balsari, 2008, The Journal of Immunology.

Lysis of autologous human melanoma cells by in vitro allosensitized peripheral blood lymphocytes

D. Taramelli, G. Parmiani, M. Sensi, 2004, Cancer Immunology, Immunotherapy.

Systemic administration of autologous, alloactivated helper-enriched lymphocytes to patients with metastatic melanoma of the lung

D. Taramelli, N. Cascinelli, G. Parmiani, 2004, Cancer Immunology, Immunotherapy.

Dansyl C‐Glucoside as a Novel Agent Against Endotoxic Shock

F. Nicotra, C. Rumio, A. Balsari, 2010, ChemMedChem.

Sodium glucose cotransporter 1 ligand BLF501 as a novel tool for management of gastrointestinal mucositis

F. Nicotra, H. Koepsell, F. Marcucci, 2014, Molecular Cancer.

Sodium-Dependent Glucose Transporter-1 as a Novel Immunological Player in the Intestinal Mucosa1

C. Rumio, A. Balsari, S. Selleri, 2008, The Journal of Immunology.

Gut Microbiota Condition the Therapeutic Efficacy of Trastuzumab in HER2-Positive Breast Cancer

L. De Cecco, C. Tripodo, L. Villani, 2021, Cancer Research.

Immunochemical analysis of the determinant recognized by a monoclonal antibody (MBr1) which specifically binds to human mammary epithelial cells.

S. Canevari, S. Sonnino, A. Balsari, 1983, Cancer research.

Virucidal activity of organic acids

C. Cantoni, A. Balsari, F. Uberti, 1979 .

S. Ménard, A. Balsari, L. Sfondrini, 2003 .

Activity and resistance of trastuzumab according to different clinical settings.

M. Campiglio, S. Ménard, E. Tagliabue, 2012, Cancer treatment reviews.

HER2 as a target for breast cancer therapy

M. Campiglio, E. Tagliabue, A. Balsari, 2010, Expert opinion on biological therapy.

Expression Profile of Tyrosine Phosphatases in HER2 Breast Cancer Cells and Tumors

E. Villa-Moruzzi, E. Tagliabue, T. Triulzi, 2010, Cellular oncology : the official journal of the International Society for Cellular Oncology.

Antitumor Activity of the TLR-5 Ligand Flagellin in Mouse Models of Cancer1

S. Ménard, E. Tagliabue, A. Merlo, 2006, The Journal of Immunology.

Lymphoid infiltration as a prognostic variable for early-onset breast carcinomas.

S. Ménard, N. Cascinelli, F. Rilke, 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.

Neoplastic and Stromal Cells Contribute to an Extracellular Matrix Gene Expression Profile Defining a Breast Cancer Subtype Likely to Progress

S. Ménard, M. Colombo, M. Carcangiu, 2013, PloS one.

Correlation between tumor vascularity, vascular endothelial growth factor production by tumor cells, serum vascular endothelial growth factor levels, and serum angiogenic activity in patients with breast carcinoma.

S. Ménard, A. Balsari, J. Maier, 1999, Laboratory investigation; a journal of technical methods and pathology.

The 67 kDa laminin receptor increases tumor aggressiveness by remodeling laminin-1.

M. Campiglio, S. Ménard, V. Berno, 2005, Endocrine-related cancer.

HER2 as a Prognostic Factor in Breast Cancer

S. Ménard, R. Agresti, A. Balsari, 2001, Oncology.

Combined targeting of EGFR and HER2 against prostate cancer stem cells

E. Tagliabue, T. Triulzi, A. Balsari, 2020, Cancer biology & therapy.

Stimulation of TLRs by LMW‐HA induces self‐defense mechanisms in vaginal epithelium

L. Battini, C. Rumio, A. Balsari, 2011, Immunology and cell biology.

Aerosol Delivery in the Treatment of Lung Cancer.

E. Tagliabue, A. Balsari, M. Sommariva, 2015, Current cancer drug targets.

Intratibial injection of an anti-doxorubicin monoclonal antibody prevents drug-induced myelotoxicity in mice.

S. Ménard, D. Morelli, A. Balsari, 1997, British Journal of Cancer.

Induction of pro-inflammatory programs in enteroendocrine cells by the Toll-like receptor agonists flagellin and bacterial LPS.

F. Marincola, E. Wang, C. Rumio, 2008, International immunology.

Expression of CD28 on CD8+ and CD4+ Lymphocytes During HIV Infection

R. Cattaneo, A. Balsari, A. Caruso, 1994, Scandinavian journal of immunology.

Mechanisms of hyperprogressive disease after immune checkpoint inhibitor therapy: what we (don’t) know

C. Moscheni, M. Garassino, E. Tagliabue, 2020, Journal of experimental & clinical cancer research : CR.

HER2 signaling regulates the tumor immune microenvironment and trastuzumab efficacy

M. Carcangiu, E. Tagliabue, T. Triulzi, 2018, Oncoimmunology.

Relevance of Antibody Valency in EGF Receptor Modulation

S. Ménard, L. Perletti, D. Morelli, 1994, Scandinavian journal of immunology.

FOXP3 expression in tumor cells and implications for cancer progression

E. Tagliabue, P. Casalini, T. Triulzi, 2013, Journal of cellular physiology.

Antibody–Fc/FcR Interaction on Macrophages as a Mechanism for Hyperprogressive Disease in Non–small Cell Lung Cancer Subsequent to PD-1/PD-L1 Blockade

V. Torri, A. Bardelli, M. Colombo, 2018, Clinical Cancer Research.

PDGFRβ and FGFR2 mediate endothelial cell differentiation capability of triple negative breast carcinoma cells

M. Iorio, M. Campiglio, I. Barajon, 2014, Molecular oncology.

HER-2-positive breast carcinomas as a particular subset with peculiar clinical behaviors.

M. Campiglio, S. Ménard, N. Cascinelli, 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

Evaluation of the balance between angiogenic and antiangiogenic circulating factors in patients with breast and gastrointestinal cancers.

S. Ménard, D. Morelli, A. Balsari, 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.

The lung microbiota: role in maintaining pulmonary immune homeostasis and its implications in cancer development and therapy

E. Tagliabue, A. Balsari, M. Sommariva, 2020, Cellular and Molecular Life Sciences.

Activation of smooth muscle and myenteric plexus cells of jejunum via toll‐like receptor 4

S. Akira, S. Ménard, S. Uematsu, 2006, Journal of cellular physiology.

Expansion of rare CD8+ CD28- CD11b- T cells with impaired effector functions in HIV-1-infected patients.

G. Alessandri, E. Garrafa, A. Balsari, 2000, Journal of acquired immune deficiency syndromes.

Eradication of Ovarian Tumor Xenografts by Locoregional Administration of Targeted Immunotherapy

S. Ménard, F. Zunino, M. de Cesare, 2008, Clinical Cancer Research.

Cross‐talk between Toll‐like receptors 5 and 9 on activation of human immune responses

S. Ménard, A. Merlo, A. Balsari, 2007, Journal of leukocyte biology.

Activation of Enteroendocrine Cells via TLRs Induces Hormone, Chemokine, and Defensin Secretion1

C. Rumio, A. Balsari, S. Selleri, 2007, The Journal of Immunology.

Macrophages Impair TLR9 Agonist Antitumor Activity through Interacting with the Anti-PD-1 Antibody Fc Domain

M. Colombo, E. Tagliabue, A. Balsari, 2021, Cancers.

Activation of NK cell cytotoxicity by aerosolized CpG-ODN/poly(I:C) against lung melanoma metastases is mediated by alveolar macrophages.

E. Tagliabue, A. Balsari, M. Sommariva, 2017, Cellular immunology.

TLR9 agonists oppositely modulate DNA repair genes in tumor versus immune cells and enhance chemotherapy effects.

S. Ménard, L. De Cecco, D. Delia, 2011, Cancer research.

Matured human monocyte-derived dendritic cells (MoDCs) induce expansion of CD4+CD25+FOXP3+ T cells lacking regulatory properties.

S. Ménard, E. Tagliabue, A. Merlo, 2008, Immunology letters.

Deep Insight Section FOXP 3 expression in tumor cells and its role in cancer progression

E. Tagliabue, P. Casalini, T. Triulzi, 2015 .

Antitumor Efficacy of Trastuzumab in Nude Mice Orthotopically Xenografted With Human Pancreatic Tumor Cells Expressing Low Levels of HER-2/neu

S. Ménard, F. Zunino, G. Petrangolini, 2008, Journal of immunotherapy.

HER2 O verexpression a nd D oxorubicin i n A djuvant Chemotherapy f or R esectable B reast C ancer

S. Ménard, G. Bonadonna, S. Pilotti, 2003 .

Increased Sensitivity to Chemotherapy Induced by CpG-ODN Treatment Is Mediated by microRNA Modulation

M. Iorio, L. De Cecco, S. Canevari, 2013, PloS one.

Toll-like receptor 3 as a new marker to detect high risk early stage Non-Small-Cell Lung Cancer patients

U. Pastorino, G. Sozzi, M. Milione, 2019, Scientific Reports.

Role of proliferation in HER2 status predicted response to doxorubicin

M. Campiglio, S. Ménard, N. Zaffaroni, 2003, International journal of cancer.

Breast carcinoma in young patients

S. Ménard, N. Cascinelli, P. Casalini, 2000, The Lancet.

Exploiting poly(I:C) to induce cancer cell apoptosis

E. Tagliabue, A. Balsari, F. Bianchi, 2017, Cancer biology & therapy.

Maspin influences response to doxorubicin by changing the tumor microenvironment organization

M. Carcangiu, E. Tagliabue, P. Casalini, 2014, International journal of cancer.

ELISA for toxoplasma antibody detection: a comparison with other serodiagnostic tests.

M. Dovis, A. Balsari, E. Rolleri, 1980, Journal of clinical pathology.

Contribution of CD 4 1 , CD 8 1 CD 28 1 , and CD 8 1 CD 28 2 T cells to CD 3 1 Lymphocyte Homeostasis during the Natural Course of HIV-1 Infection

A. Balsari, F. Malacarne, S. Fiorentini, 1997 .

FOXP3 expression in tumor cells and its role in cancer progression

E. Tagliabue, P. Casalini, T. Triulzi, 2015 .

Control of human melanoma growth in nude mice by autologous allo‐activated peripheral blood lymphocytes

M. Colombo, G. Parmiani, A. Balsari, 1986, International journal of cancer.

Inhibition of Human Melanoma Growth in Nude Mice by Autologous, Alloactivated Peripheral Blood Lymphocytes

D. Taramelli, G. Parmiani, A. Balsari, 1984, Tumori.

Tumorigenicity and dissemination of primary and metastatic human melanomas implanted into different sites in athymic nude mice.

G. Parmiani, M. Rodolfo, A. Balsari, 1988, Invasion & metastasis.

Both Naive/Memory and Effector Cells of Lymphocytes with Phenotype and Function CD11b Expression Identifies CD8+CD28+ T

G. Alessandri, A. Balsari, S. Caligaris, 2013 .

CD11b Expression Identifies CD8+CD28+ T Lymphocytes with Phenotype and Function of Both Naive/Memory and Effector Cells1

F. Castelli, G. Alessandri, E. Garrafa, 2001, The Journal of Immunology.

Influence of fatty acid‐free diet on mammary tumor development and growth rate in HER‐2/neu transgenic mice

C. Rumio, D. Morelli, E. Tagliabue, 2013, Journal of cellular physiology.

Epithelium–mesenchyme compartment interaction and oncosis on chemotherapy-induced hair damage

C. Rumio, A. Balsari, L. Vizzotto, 2004, Laboratory Investigation.

Molecular Phenotype Distinguishes Two Subsets of Gastric Low-Grade Mucosa-Associated Lymphoid Tissue Lymphomas

S. Ménard, A. Balsari, E. Nardini, 2002, Laboratory Investigation.

Contribution of CD4+, CD8+CD28+, and CD8+CD28- T cells to CD3+ lymphocyte homeostasis during the natural course of HIV-1 infection.

A. Balsari, F. Malacarne, S. Fiorentini, 1998, The Journal of clinical investigation.

Expression of activation markers on peripheral-blood lymphocytes following oral administration of Bacillus subtilis spores.

A. Balsari, I. Foresti, A. Caruso, 1993, International Journal of Immunopharmacology.

Doxorubicin-induced alopecia is associated with sebaceous gland degeneration.

C. Zouboulis, C. Rumio, A. Balsari, 2006, The Journal of investigative dermatology.

Expression and prognostic significance of the autoimmune regulator gene in breast cancer cells

L. De Cecco, E. Tagliabue, T. Triulzi, 2016, Cell cycle.

TLR3 Expression Induces Apoptosis in Human Non-Small-Cell Lung Cancer

M. Milione, E. Tagliabue, M. Truini, 2020, International journal of molecular sciences.

Toll-like receptor agonists regulate beta-defensin 2 release in hair follicle.

C. Rumio, A. Balsari, S. Selleri, 2007, The British journal of dermatology.

Inhibition of DNA Repair Mechanisms and Induction of Apoptosis in Triple Negative Breast Cancer Cells Expressing the Human Herpesvirus 6 U94

C. Fraefel, F. Giordano, A. Balsari, 2019, Cancers.

Effect of adjuvant trastuzumab treatment in conventional clinical setting: an observational retrospective multicenter Italian study

M. Campiglio, S. Ménard, V. Adamo, 2013, Breast Cancer Research and Treatment.

Prevention of spontaneous mammary adenocarcinoma in HER‐2/neu transgenic mice by foreign DNA

S. Ménard, C. Rumio, M. Rodolfo, 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Influence of antibiotic treatment on breast carcinoma development in proto-neu transgenic mice.

L. Mariani, S. Ménard, R. Miceli, 2006, Cancer research.

Human renal antigen defined by a murine monoclonal antibody.

S. Ménard, S. Canevari, E. Tagliabue, 1984, Journal of the National Cancer Institute.

A new monoclonal antibody recognizing anthracyclinic molecule.

S. Ménard, D. Morelli, E. Tagliabue, 1990, Anticancer research.

Biology, prognosis and response to therapy of breast carcinomas according to HER2 score.

S. Ménard, P. Querzoli, F. Marandino, 2008, Annals of oncology : official journal of the European Society for Medical Oncology.

Linking survival of HER2-positive breast carcinoma patients with surgical invasiveness.

L. Mariani, S. Ménard, U. Veronesi, 2006, European journal of cancer.

Ascites Regression and Survival Increase in Mice Bearing Advanced-stage Human Ovarian Carcinomas and Repeatedly Treated Intraperitoneally With CpG-ODN

M. Campiglio, F. Zunino, R. Supino, 2010, Journal of immunotherapy.

Modulation of DNA repair genes induced by TLR9 agonists

L. De Cecco, E. Tagliabue, A. Balsari, 2012, Oncoimmunology.

Proliferation of breast carcinoma during menstrual phases

S. Ménard, S. Pilotti, P. Casalini, 1998, The Lancet.

miR-302b enhances breast cancer cell sensitivity to cisplatin by regulating E2F1 and the cellular DNA damage response

Carlo M. Croce, Marilena V. Iorio, C. Croce, 2015, Oncotarget.

Influence of Lignans Depletion on Murine Mammary Gland Morphology

C. Rumio, D. Morelli, E. Tagliabue, 2010, Nutrition and cancer.

Re: Estimation of tamoxifen's efficacy for preventing the formation and growth of breast tumors.

M. Campiglio, S. Ménard, E. Tagliabue, 2000, Journal of the National Cancer Institute.

The Differential Response to Interferon γ by Normal and Transformed Endothelial Cells

D. Morelli, A. Balsari, J. Maier, 1995 .

Increase in the therapeutic effect of doxorubicin induced by monoclonal antibodies raised against this drug.

S. Ménard, A. Sardini, D. Morelli, 1992, Pharmacological research.

Fluctuation of HER2 expression in breast carcinomas during the menstrual cycle.

S. Ménard, N. Cascinelli, M. Greco, 1999, The American journal of pathology.

HER2 and proliferation of wound-induced breast carcinoma

M. Campiglio, S. Ménard, E. Tagliabue, 2003, The Lancet.

Natural human antibodies to gamma interferon interfere with the immunomodulating activity of the lymphokine.

S. Landolfo, A. Balsari, F. Gargiulo, 1992, Proceedings of the National Academy of Sciences of the United States of America.

Serological comparison of Bovid herpesvirus 2 and Herpes simplex virus by reciprocal neutralization kinetic studies.

A. Balsari, F. Uberti, G. Poli, 1980, Comparative immunology, microbiology and infectious diseases.

Two Distinct Local Relapse Subtypes in Invasive Breast Cancer: Effect on their Prognostic Impact

S. Ménard, V. Kosma, M. Greco, 2008, Clinical Cancer Research.

Evaluation of the antimicrobial activity of disinfectants

A. Balsari, G. Poli, W. Ponti, 1979 .

Activation of NK cells cytotoxicity mediated by alveolar macrophages in the lung against murine melanoma metastases by combined aerosol immunotherapy

E. Tagliabue, A. Balsari, M. Sommariva, 2017 .

Microplate enzyme-linked immunosorbent assay for bovine leukemia virus antibody

A. Toniolo, A. Balsari, G. Poli, 1981, Journal of Clinical Microbiology.

Skin and perivascular toxicity induced experimentally by doxorubicin.

A. Balsari, M. Ghione, N. Lombardo, 1989, Journal of chemotherapy.

Surveillance of spontaneous breast cancer metastasis by TRAIL-expressing CD34+ cells in a xenograft model

E. Tagliabue, A. Balsari, A. Giacomini, 2012, Breast Cancer Research and Treatment.

T cells from individuals in advanced stages of HIV-1 infection do not proliferate but express activation antigens in response to HIV-1-specific antigens.

A. Balsari, S. Fiorentini, A. Caruso, 1997, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

Advances in Brief Tamoxifen Chemoprevention of a Hormone-independent Tumor in the Proto-neu Transgenic Mice Model 1

S. Ménard, P. Lollini, C. Rumio, 2000 .

ANTI-TUMOR ACTIVITY OF CPG-ODN IN OVARIAN XENOGRAFT TUMORS

A. Balsari, L. Sfondrini, D. Milano, 2014 .

Identification of HER2-positive breast carcinomas as a particular subset with peculiar clinical behaviours

M. Campiglio, S. Ménard, N. Cascinelli, 2001 .

miR-302b enhances breast cancer cell sensitivity to cisplatin by regulating E2F1 and the cellular DNA damage response

C. Croce, M. Iorio, V. Coppola, 2015, Oncotarget.

CpG-oligodeoxynucleotides exert remarkable antitumor activity against diffuse malignant peritoneal mesothelioma orthotopic xenografts

N. Zaffaroni, M. Pennati, C. De Marco, 2016, Journal of Translational Medicine.

FOXP3 EXPRESSION IN BREAST CARCINOMA CELLS AND METASTATIC SPREAD

A. Balsari, L. Sfondrini, D. Milano, 2014 .